Humana Inc

• Humana's stock rose due to favorable Medicare Advantage Star Ratings updates. • Most enrollees are now covered by plans receiving four stars or higher. • Higher ratings unlock federal bonus payments, supporting margin expansion and profitability.

• UnitedHealth Group surged on pre-earnings institutional positioning and operational recovery optimism. • Strategic Medicare Advantage plan recalibrations reinforced investor confidence in margin expansion. • The stock attracted bargain hunting amid favorable sentiment and defensive exposure demand.

• Barclays upgraded Humana to Overweight, raising its price target significantly. • Anticipated CMS Star Ratings improvements boost federal quality bonus payment prospects. • Management executes margin restoration while expanding CenterWell primary care services.

• ResMed reported strong recurring revenue from its AirSense platform and software ecosystem. • Clinical insights suggest GLP-1 drugs increase sleep apnea diagnosis rates and patient engagement. • ResMed solidified market share as its primary competitor faces ongoing regulatory constraints.